Hidehiro Ishii
- Ophthalmology top 1%
- Retinal Diseases and Treatments 3
- Clinical Biochemistry top 1%
- Advanced Glycation End Products research 2
- Neurology top 10%
-
- Diabetes Treatment and Management 5
- Nephrology top 5%
-
- Metabolism, Diabetes, and Cancer 5
- Retinal Development and Disorders 2
-
- Diabetes and associated disorders 3
-
- Nitric Oxide and Endothelin Effects 2
-
- Infectious Diseases and Tuberculosis 2
Hidehiro Ishii
17 papers receiving 1.4k citations
Hit Papers
Peers
Comparison fields: 5 of 81
- Ophthalmology 454
- Clinical Biochemistry 284
- Neurology 117
- Endocrinology, Diabetes and Metabolism 235
- Nephrology 88
Countries citing papers authored by Hidehiro Ishii
This map shows the geographic impact of Hidehiro Ishii's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hidehiro Ishii with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hidehiro Ishii more than expected).
Fields of papers citing papers by Hidehiro Ishii
This network shows the impact of papers produced by Hidehiro Ishii. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hidehiro Ishii. The network helps show where Hidehiro Ishii may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hidehiro Ishii, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2026 | 0 | |
| 2 | 2023 | 1 | |
| 3 | 2023 | 0 | |
| 4 | 2022 | 0 | |
| 5 | 2021 | 1 | |
| 6 | 2018 | 3 | |
| 7 | Secondary Failure of Troglitazone in Type 2 Diabetic Patients and its Predictive Factors | 2001 | 1 |
| 8 | 2000 | 18 | |
| 9 | 1999 | 343 | |
| 10 | 1998 | 163 | |
| 11 | Vascular Endothelial Growth Factor–Induced Retinal Permeability Is Mediated by Protein Kinase C In Vivo and Suppressed by an Orally Effective β-Isoform–Selective Inhibitorbreakdown → | 1997 | 515 |
| 12 | 1997 | 219 | |
| 13 | Specific retinal diacylglycerol and protein kinase C beta isoform modulation mimics abnormal retinal hemodynamics in diabetic rats. | 1997 | 68 |
| 14 | 1992 | 33 | |
| 15 | Platelet-derived growth factor and growth-promoting activity in the serum samples and platelets of patients with non-insulin-dependent diabetes mellitus. | 1992 | 10 |
| 16 | 1992 | 1 | |
| 17 | 1991 | 9 | |
| 18 | 1990 | 37 | |
| 19 | 1989 | 1 | |
| 20 | 1988 | 1 |
About Hidehiro Ishii
Hidehiro Ishii is a scholar working on Endocrinology, Diabetes and Metabolism, Ophthalmology and Clinical Biochemistry, having authored 21 papers that have together received 1.4k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (5 papers), Metabolism, Diabetes, and Cancer (5 papers), Retinal Diseases and Treatments (3 papers), Diabetes and associated disorders (3 papers), Nitric Oxide and Endothelin Effects (2 papers), Infectious Diseases and Tuberculosis (2 papers), Retinal Development and Disorders (2 papers) and Advanced Glycation End Products research (2 papers). The work is most often cited by research in Ophthalmology (454 citations), Clinical Biochemistry (284 citations) and Neurology (117 citations). Hidehiro Ishii has collaborated with scholars based in Japan, United States and China. Frequent co-authors include George L. King, Daisuke Koya, Chikako Takagi, Lloyd Paul Aiello, Thomas A. Ciulla, Fumi Mori, Lois E. H. Smith, Allen C. Clermont, Kirk Ways and Michael R. Jirousek. Their work appears in journals such as Diabetes, Journal of Molecular Medicine, Journal of Clinical Investigation, Endocrine Journal and Internal Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.